Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation

Neuroscience

Volumn 193, Issue , 2011, Pages 452-465

  Hoffman, E M ^a   Zhang, Z ^a   Anderson, M B ^a   Schechter, R ^a   Miller, K E ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Calcitonin gene related peptide; Glutaminase; Intraepidermal nerve fibers; Nav1.8; Substance P; Tanezumab

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYTOCHROME C; GLUTAMINASE; IMMUNOGLOBULIN ANTIBODY; ISOLECTIN B4; NERVE GROWTH FACTOR ANTIBODY; SODIUM CHANNEL NAV1.8; TANEZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DENSITY; CONTROLLED STUDY; FEMALE; HOT PLATE TEST; HYPOALGESIA; IMMUNIZATION; MALE; NERVE FIBER; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MALNUTRITION; RAT; SPINAL GANGLION; TAIL FLICK TEST;

AGE FACTORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CALCITONIN GENE-RELATED PEPTIDE; CYTOCHROMES C; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIA, SPINAL; GLYCOPROTEINS; IMMUNOGLOBULINS; INFLAMMATION; MALE; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; PAIN; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNELS; SUBSTANCE P;

EID: 80052495481     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.06.069     Document Type: Article

References (96)

1. Abdiche Y.N., Malashock D.S., Pons J. Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. Protein Sci 2008, 17:1326-1335.
2. Abrahamsen B., Zhao J., Asante C.O., Cendan C.M., Marsh S., Martinez-Barbera J.P., Nassar M.A., Dickenson A.H., Wood J.N. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 2008, 321:702-705.
3. Akopian A.N., Sivilotti L., Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996, 379:257-262.
4. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dickenson A.H., Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999, 2:541-548.
5. Albers K.M., Wright D.E., Davis B.M. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994, 14:1422-1432.
6. Alvarez F.J., Cervantes C., Blasco I., Villalba R., Martinez-Murillo R., Polak J.M., Rodrigo J. Presence of calcitonin gene-related peptide (CGRP) and substance P (SP) immunoreactivity in intraepidermal free nerve endings of cat skin. Brain Res 1988, 442:391-395.
7. Averill S., McMahon S.B., Clary D.O., Reichardt L.F., Priestley J.V. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 1995, 7:1484-1494.
8. Beiswenger K.K., Calcutt N.A., Mizisin A.P. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett 2008, 442:267-272.
9. Bennett D.L., Koltzenburg M., Priestley J.V., Shelton D.L., McMahon S.B. Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur J Neurosci 1998, 10:1282-1291.
10. Brown C. Blood collection from the tail of a rat. Lab Anim (NY) 2006, 35:24-25.
11. Brumovsky P., Watanabe M., Hökfelt T. Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neuroscience 2007, 147:469-490.
12. Burgess G., Williams D. The discovery and development of analgesics: new mechanisms, new modalities. J Clin Invest 2010, 120:3753-3759.
13. Carlton S.M. Peripheral excitatory amino acids. Curr Opin Pharmacol 2001, 1:52-56.
14. Carlton S.M., Zhou S., Coggeshall R.E. Localization and activation of substance P receptors in unmyelinated axons of rat glabrous skin. Brain Res 1996, 734:103-108.
15. Casanova-Molla J., Grau-Junyent J.M., Morales M., Valls-Solé J. On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies. Pain 2011, 152:410-418.
16. Cattaneo A. Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain. Curr Opin Mol Ther 2010, 12:94-106.
17. Cheng H.T., Dauch J.R., Hayes J.M., Hong Y., Feldman E.L. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol 2009, 68:1229-1243.
18. Chudler E.H., Anderson L.C., Byers M.R. Nerve growth factor depletion by autoimmunization produces thermal hypoalgesia in adult rats. Brain Res 1997, 765:327-330.
19. Colquhoun A., Lawrance G.M., Shamovsky I.L., Riopelle R.J., Ross G.M. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA. J Pharmacol Exp Ther 2004, 310:505-511.
20. Covaceuszach S., Cattaneo A., Lamba D. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight. Proteins 2005, 58:717-727.
21. deGroot J., Zhou S., Carlton S.M. Peripheral glutamate release in the hind paw following low and high intensity sciatic stimulation. Neuroreport 2000, 11:497-502.
22. Dib-Hajj S.D., Cummins T.R., Black J.A., Waxman S.G. Sodium channels in normal and pathological pain. Annu Rev Neurosci 2010, 33:325-347.
23. Djouhri L., Dawbarn D., Robertson A., Newton R., Lawson S.N. Time course and nerve growth factor dependence of inflammation-induced alterations in electrophysiological membrane properties in nociceptive primary afferent neurons. J Neurosci 2001, 21:8722-8733.
24. Fang X., Djouhri L., McMullan S., Berry C., Waxman S.G., Okuse K., Lawson S.N. Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav19 expression. J Neurosci 2006, 26:7281-7292.
25. Fjell J., Cummins T.R., Fried K., Black J.A., Waxman S.G. In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. J Neurophysiol 1999, 81:803-810.
26. Friess H., Zhu Z.W., di Mola F.F., Kulli C., Graber H.U., Andren-Sandberg A., Zimmermann A., Korc M., Reinshagen M., Büchler M.W. Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999, 230:615-624.
27. Fukui Y., Ohtori S., Yamashita M., Yamauchi K., Inoue G., Suzuki M., Orita S., Eguchi Y., Ochiai N., Kishida S., Takaso M., Wakai K., Hayashi Y., Aoki Y., Takahashi K. Low affinity NGF receptor (p75 neurotrophin receptor) inhibitory antibody reduces pain behavior and CGRP expression in DRG in the mouse sciatic nerve crush model. J Orthop Res 2010, 28:279-283.
28. Fukuoka T., Kobayashi K., Yamanaka H., Obata K., Dai Y., Noguchi K. Comparative study of the distribution of the alpha-subunits of voltage-gated sodium channels in normal and axotomized rat dorsal root ganglion neurons. J Comp Neurol 2008, 510:188-206.
29. Gorin P.D., Johnson E.M. Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: an experimental autoimmune approach. Brain Res 1980, 198:27-42.
30. Gorin P.D., Johnson E.M. Experimental autoimmune model of nerve growth factor deprivation: effects on developing peripheral sympathetic and sensory neurons. Proc Natl Acad Sci U S A 1979, 76:5382-5386.
31. Gould H.J., Gould T.N., England J.D., Paul D., Liu Z.P., Levinson S.R. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res 2000, 854:19-29.
32. Halliday D.A., Zettler C., Rush R.A., Scicchitano R., McNeil J.D. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res 1998, 23:919-922.
33. Hamed K., Giles N., Anderson J., Phillips J.K., Dawson L.F., Drummond P., Wallace H., Wood F.M., Rea S.M., Fear M.W. Changes in cutaneous innervation in patients with chronic pain after burns. Burns 2011, 37(4):631-637.
34. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
35. Hefti F.F., Rosenthal A., Walicke P.A., Wyatt S., Vergara G., Shelton D.L., Davies A.M. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 2006, 27:85-91.
36. Hoffman E.M., Miller K.E. Peripheral inhibition of glutaminase reduces carrageenan-induced Fos expression in the superficial dorsal horn of the rat. Neurosci Lett 2010, 472:157-160.
37. Hoffman E.M., Schechter R., Miller K.E. Fixative composition alters distributions of immunoreactivity for glutaminase and two markers of nociceptive neurons, Nav18 and TRPV1, in the rat dorsal root ganglion. J Histochem Cytochem 2010, 58:329-344.
38. Hoffman G.E., Le W.W. Just cool it! Cryoprotectant anti-freeze in immunocytochemistry and in situ hybridization. Peptides 2004, 25:425-431.
39. Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum Mutat 2001, 18:462-471.
40. Indo Y. Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis. Expert Rev Neurother 2010, 10:1707-1724.
41. Iwakura N., Ohtori S., Orita S., Yamashita M., Takahashi K., Kuniyoshi K. Role of low-affinity nerve growth factor receptor inhibitory antibody in reducing pain behavior and calcitonin gene-related peptide expression in a rat model of wrist joint inflammatory pain. J Hand Surg Am 2010, 35:267-273.
42. Jarvis M.F., Honore P., Shieh C.C., Chapman M., Joshi S., Zhang X.F., Kort M., Carroll W., Marron B., Atkinson R., Thomas J., Liu D., Krambis M., Liu Y., McGaraughty S., Chu K., Roeloffs R., Zhong C., Mikusa J.P., Hernandez G., Gauvin D., Wade C., Zhu C., Pai M., Scanio M., Shi L., Drizin I., Gregg R., Matulenko M., Hakeem A., Gross M., Johnson M., Marsh K., Wagoner P.K., Sullivan J.P., Faltynek C.R., Krafte D.S. A-803467, a potent and selective Nav18 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A 2007, 104:8520-8525.
43. Jin Y.H., Nishioka H., Wakabayashi K., Fujita T., Yonehara N. Effect of morphine on the release of excitatory amino acids in the rat hind instep: pain is modulated by the interaction between the peripheral opioid and glutamate systems. Neuroscience 2006, 138:1329-1339.
44. Johnson E.M., Gorin P.D., Osborne P.A., Rydel R.E., Pearson J. Effects of autoimmune NGF deprivation in the adult rabbit and offspring. Brain Res 1982, 240:131-140.
45. Kashiba H., Uchida Y., Senba E. Difference in binding by isolectin B4 to trkA and c-ret mRNA-expressing neurons in rat sensory ganglia. Brain Res Mol Brain Res 2001, 95:18-26.
46. Kashiba H., Ueda Y., Senba E. Systemic capsaicin in the adult rat differentially affects gene expression for neuropeptides and neurotrophin receptors in primary sensory neurons. Neuroscience 1997, 76:299-312.
47. Kawamura M., Kuraishi Y., Minami M., Satoh M. Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res 1989, 497:199-203.
48. Kennedy W.R., Wendelschafer-Crabb G. Pathology and quantification of cutaneous nerves. Peripheral neuropathy 2005, 869-896. Saunders, Philadelphia. P.J. Dyck, P.K. Thomas (Eds.).
49. Kinkelin I., Mötzing S., Koltenzenburg M., Bröcker E.B. Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res 2000, 302:31-37.
50. Knyihar-Csillik E., Vecsei L., Mihaly A., Fenyo R., Farkas I., Krisztin-Peva B., Csillik B. Effect of vinpocetine on retrograde axoplasmic transport. Ann Anat 2007, 189:39-45.
51. Koltzenburg M., Bennett D.L., Shelton D.L., McMahon S.B. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur J Neurosci 1999, 11:1698-1704.
52. Kuraishi Y., Nanayama T., Ohno H., Minami M., Satoh M. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett 1988, 92:325-329.
53. Lane N.E., Schnitzer T.J., Birbara C.A., Mokhtarani M., Shelton D.L., Smith M.D., Brown M.T. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010, 363:1521-1531.
54. Lawson S.N., McCarthy P.W., Prabhakar E. Electrophysiological properties of neurones with CGRP-like immunoreactivity in rat dorsal root ganglia. J Comp Neurol 1996, 365:355-366.
55. Le Bars D., Gozariu M., Cadden S.W. Animal models of nociception. Pharmacol Rev 2001, 53:597-652.
56. Levi-Montalcini R., Booker B. Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein. Proc Natl Acad Sci U S A 1960, 46:384-391.
57. Li J.L., Ohishi H., Kaneko T., Shigemoto R., Neki A., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR7, in ganglion neurons of the rat; with special reference to the presence in glutamatergic ganglion neurons. Neurosci Lett 1996, 204:9-12.
58. Lu Y., Pirec V., Yeomans D.C. Differential antinociceptive effects of spinal opioids on foot withdrawal responses evoked by C fibre or A delta nociceptor activation. Br J Pharmacol 1997, 121:1210-1216.
59. Ma Q.P., Woolf C.J. The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent. Neuroreport 1997, 8:807-810.
60. McDougal D.B., Yu M.J., Gorin P.D., Johnson E.M. Transported enzymes in sciatic nerve and sensory ganglia of rats exposed to maternal antibodies against nerve growth factor. J Neurochem 1981, 36:1847-1852.
61. McMahon S.B. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci 1996, 351:431-440.
62. McMahon S.B., Armanini M.P., Ling L.H., Phillips H.S. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994, 12:1161-1171.
63. McMahon S.B., Bennett D.L., Priestley J.V., Shelton D.L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995, 1:774-780.
64. Merighi A., Polak J.M., Theodosis D.T. Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide. Neuroscience 1991, 40:67-80.
65. Miller K.E., Douglas V.D., Kaneko T. Glutaminase immunoreactive neurons in the rat dorsal root ganglion contain calcitonin gene-related peptide (CGRP). Neurosci Lett 1993, 160:113-116.
66. Miller K.E., Herzog B.H., Edwards K.M., Kriebel R.M. Intraplantar glutaminase inhibition: analgesic dose response of 6-diazo-5-oxo-l-norleucine during adjuvant induced arthritis in rats. Proc Soc Neurosci 2006, 249.10.
67. Miller KE, Herzog BH, Sutharshan M (2010) 6-diazo-5-oxo-L-norleucine: a glutaminase inhibitor with local analgesic properties. 13th World Congress on Pain, PT 421.
68. Miller K.E., Hoffman E.M., Sutharshan M., Schechter R. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther 2011, 130(3):283-309.
69. Miller L.J., Fischer K.A., Goralnick S.J., Litt M., Burleson J.A., Albertsen P., Kreutzer D.L. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59:603-608.
70. Nakamura-Craig M., Gill B.K. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett 1991, 124:49-51.
71. Omote K., Kawamata T., Kawamata M., Namiki A. Formalin-induced release of excitatory amino acids in the skin of the rat hind paw. Brain Res 1998, 787:161-164.
72. Orita S., Ohtori S., Nagata M., Horii M., Yamashita M., Yamauchi K., Inoue G., Suzuki M., Eguchi Y., Kamoda H., Arai G., Ishikawa T., Miyagi M., Ochiai N., Kishida S., Takaso M., Aoki Y., Takahashi K. Inhibiting nerve growth factor or its receptors downregulates calcitonin gene-related peptide expression in rat lumbar dorsal root ganglia innervating injured intervertebral discs. J Orthop Res 2010, 28:1614-1620.
73. Otten U., Goedert M., Schwab M., Thibault J. Immunization of adult rats against 2.5 S NGF: effects on the peripheral sympathetic nervous system. Brain Res 1979, 176:79-90.
74. Owolabi J.B., Rizkalla G., Tehim A., Ross G.M., Riopelle R.J., Kamboj R., Ossipov M., Bian D., Wegert S., Porreca F., Lee D.K. Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat. J Pharmacol Exp Ther 1999, 289:1271-1276.
75. Pedersen-Bjergaard U., Nielsen L.B., Jensen K., Edvinsson L., Jansen I., Olesen J. Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 1991, 12:333-337.
76. Pezet S., McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006, 29:507-538.
77. Phillips H.S., Armanini M.P. Expression of the trk family of neurotrophin receptors in developing and adult dorsal root ganglion neurons. Philos Trans R Soc Lond B Biol Sci 1996, 351:413-416.
78. Pittenger G.L., Ray M., Burcus N.I., McNulty P., Basta B., Vinik A.I. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 2004, 27:1974-1979.
79. Plone M.A., Emerich D.F., Lindner M.D. Individual differences in the hot plate test and effects of habituation on sensitivity to morphine. Pain 1996, 66:265-270.
80. Price T.J., Flores C.M. Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain 2007, 8:263-272.
81. Sann H., Pierau F.K. Efferent functions of C-fiber nociceptors. Z Rheumatol 1998, 57(Suppl 2):8-13.
82. Schicho R., Donnerer J. Nerve growth factor stimulates synthesis of calcitonin gene-related peptide in dorsal root ganglion cells during sensory regeneration in capsaicin-treated rats. Neurosci Res 1999, 35:183-187.
83. Schnitzer T.J., Lane N.E., Birbara C., Smith M.D., Simpson S.L., Brown M.T. Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain. Osteoarthritis Cartilage 2011, 19(6):639-646.
84. Selim M.M., Wendelschafer-Crabb G., Hodges J.S., Simone D.A., Foster S.X., Vanhove G.F., Kennedy W.R. Variation in quantitative sensory testing and epidermal nerve fiber density in repeated measurements. Pain 2010, 151:575-581.
85. Sevcik M.A., Ghilardi J.R., Peters C.M., Lindsay T.H., Halvorson K.G., Jonas B.M., Kubota K., Kuskowski M.A., Boustany L., Shelton D.L., Mantyh P.W. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 2005, 115:128-141.
86. Sivilia S., Paradisi M., D'Intino G., Fernandez M., Pirondi S., Lorenzini L., Calzà L. Skin homeostasis during inflammation: a role for nerve growth factor. Histol Histopathol 2008, 23:1-10.
87. Wang S., Davis B.M., Zwick M., Waxman S.G., Albers K.M. Reduced thermal sensitivity and Nav18 and TRPV1 channel expression in sensory neurons of aged mice. Neurobiol Aging 2006, 27:895-903.
88. Watson J.J., Allen S.J., Dawbarn D. Targeting nerve growth factor in pain: what is the therapeutic potential?. Biodrugs 2008, 22:349-359.
89. Wiesenfeld-Hallin Z., Xu X.J., Håkanson R., Feng D.M., Folkers K. The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in rat. Brain Res 1990, 526:284-290.
90. Wood J.N. Nerve growth factor and pain. N Engl J Med 2010, 363:1572-1573.
91. Woolf C.J., Ma Q. Nociceptors-noxious stimulus detectors. Neuron 2007, 55:353-364.
92. Woolf C.J., Safieh-Garabedian B., Ma Q.P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994, 62:327-331.
93. Yeomans D.C., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 1996, 68:141-150.
94. Zahn P.K., Sluka K.A., Brennan T.J. Excitatory amino acid release in the spinal cord caused by plantar incision in the rat. Pain 2002, 100:65-76.
95. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
96. Zorbas M., Hurst S., Shelton D., Evans M., Finco D., Butt M. A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. Regul Toxicol Pharmacol 2011, 59(2):334-342.